Abstract
A genetic algorithm (GA), driven by experimentally determined biological activities as a feedback fitness function, was used to propose novel small molecules as inhibitors of glucose-6-phosphate translocase (G6PT) in iterative rounds of evolutionary optimization. A straightforward polymer-supported synthetic sequence was implemented to synthesize molecules proposed by the GA, and the biological activities of the compounds were determined by a microsomal assay. Additional compound design strategies were integrated, such as Tanimoto similarity-based selection of starting materials and transfer of favored structure elements into a new chemical scaffold to identify more active and selective inhibitors.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antiporters / antagonists & inhibitors*
-
Diabetes Mellitus, Type 2 / enzymology*
-
Enzyme Inhibitors / chemical synthesis*
-
Enzyme Inhibitors / chemistry
-
Enzyme Inhibitors / pharmacology
-
Glucose / metabolism
-
Glucose-6-Phosphatase / antagonists & inhibitors*
-
Humans
-
Hypoglycemic Agents / chemical synthesis*
-
Hypoglycemic Agents / chemistry
-
Hypoglycemic Agents / pharmacology
-
Microsomes, Liver / drug effects
-
Microsomes, Liver / enzymology
-
Microsomes, Liver / metabolism
-
Molecular Structure
-
Monosaccharide Transport Proteins / antagonists & inhibitors*
-
Rats
Substances
-
Antiporters
-
Enzyme Inhibitors
-
Hypoglycemic Agents
-
Monosaccharide Transport Proteins
-
SLC37A4 protein, human
-
Glucose-6-Phosphatase
-
Glucose